Arcutis Biotherapeutics (NASDAQ:ARQT) Upgraded by Mizuho to Buy
Mizuho upgraded shares of Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) from a neutral rating to a buy rating in a research report report published on...
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Price Target Raised to $37.00 at Bank of America
Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) had its price objective hoisted by Bank of America from $29.00 to $37.00 in a report published on Tuesday...
Ayala Pharmaceuticals (NASDAQ:ADXS) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report released on Wednesday morning. The brokerage issued a sell...
Atlantic American (NASDAQ:AAME) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of Atlantic American (NASDAQ:AAME – Free Report) in a research report report published on Wednesday. The brokerage issued a hold...
Alkermes (NASDAQ:ALKS) PT Raised to $29.00 at Bank of America
Alkermes (NASDAQ:ALKS – Free Report) had its price objective upped by Bank of America from $27.00 to $29.00 in a report released on Tuesday morning,...
Wilhelmina International (NASDAQ:WHLM) Receives New Coverage from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Wilhelmina International (NASDAQ:WHLM – Free Report) in a research note published on Wednesday morning. The brokerage issued a buy...